跳至主要内容
临床试验/NCT04015219
NCT04015219终止不适用

A Prospective, Randomized, and Controlled Clinical Study to Evaluate PROKERA® in the Management of Signs and Symptoms Associated With Dry Eye Disease

Tissue Tech Inc.2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2018年7月18日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
3
试验地点
2
主要终点
Corneal Fluorescein Staining

研究概览

简要总结

A prospective randomized, and controlled study to compare the effectiveness of PROKERA® SLIM plus standard of care (SOC) in the PROKERA® SLIM Arm to SOC alone in the Control Arm. Subjects presenting with moderate DED defined as corneal fluorescein staining score of ≥ 3 points out of 9 will be recruited.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with moderate dry eye defined as corneal fluorescein staining score of ≥ 3
  • Age ≥ 18 years
  • Distance best corrected visual acuity better than 20/60 Snellen equivalent in each eye
  • Willing to sign a written informed consent to participate
  • Able to follow study instructions, with the intention of completing all required visits

排除标准

  • Presence of persistent corneal epithelial defect or ulcer in either eye
  • Presence of active ocular infection in either eye
  • Presence of ocular inflammation that is not related to keratoconjunctivitis sicca, e.g., allergy, severe blepharitis
  • Presence of other corneal disorder(s) that give rise to reduced corneal sensitivity, such as recurrent herpes keratitis
  • Presence of corneal diseases other than dry eye that can disturb the pre-corneal tear film such as epithelial basement membrane dystrophy (EBMD)
  • Contact lens wear
  • History of recent ocular surgery/trauma, which could affect corneal sensitivity, e.g., corneal transplantation, LASIK
  • Presence of cicatricial ocular surface diseases
  • A medical or ocular condition, or a personal situation, which in the principal investigator's opinion, is not appropriate for participation in the trial
  • Any scheduled or planned ocular or systemic surgery or procedure during the study
  • Pregnancy and women who are expecting to be pregnant.
  • Current enrolment in another interventional drug or device study or participation in such a study within 30 days of anticipated entry into this study

结局指标

主要结局

Corneal Fluorescein Staining

时间窗: 1 month

corneal fluorescein staining score of study eye graded from 0 to 9, with a score of 9 being worse. The corneal fluorescein staining score is the sum of three scores by subdividing the entire cornea into upper 1/3, middle 1/3, and lower 1/3, of which each is graded from 0 (no staining) to 3 (diffuse staining).

次要结局

  • Ocular Surface Disease Index (OSDI)(1 month)
  • Eye Dryness Score(1 month)

研究者

发起方
Tissue Tech Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验